Patents-Review.com
🔗 Permalink
Inventor profile of:

Mart Saarma

City:

Helsinki

Country:

Finland

Published Applications:

31

Last publication date:

2025-10-30

Top Assignees for applications by Mart Saarma

The entities that hold a legal rights for patent applications filed by inventor Saarma Mart:

Recent patent applications by Saarma Mart

Mart Saarma from Helsinki, FI has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-30
US20250332220A1
Human necessities

USE OF CEREBRAL DOPAMINE NEUROTROPHIC FACTOR FOR AMELIORATING PNEUMONIA

 #2 | 2021-08-12
US20210244728A1
Human necessities

Method of treating peripheral neuropathy

 #3 | 2021-01-14
US20210009645A1
Chemistry; metallurgy

C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereof

 #4 | 2020-03-05
US20200071372A1
Chemistry; metallurgy

C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereof

 #5 | 2019-06-27
US20190192629A1
Human necessities

Compositions Comprising CDNF or MANF for use in the Intranasal Treatment of Central Nervous System Diseases

 #6 | 2019-05-23
US20190153052A1
Chemistry; metallurgy

TREATMENT WITH A PHARMACEUTICAL COMPOSITION COMPRISING MANF2 NUCLEIC ACID

 #7 | 2017-05-25
US20170145066A1
Chemistry; metallurgy

Splice variants of GDNF and uses thereof

 #8 | 2015-07-23
US20150202263A1
Human necessities

Neurturin molecules

 #9 | 2015-05-21
US20150141329A9
Chemistry; metallurgy

Neurturin molecules

 #10 | 2015-01-15
US20150020222A1
Human necessities

Neurotrophic factor MANF and uses thereof

 #11 | 2014-09-11
US20140259192A1
Human necessities

TRANSGENIC ANIMAL COMPRISING A DELETION OR FUNCTIONAL DELETION OF THE 3'UTR OF AN ENDOGENOUS GENE

 #12 | 2013-10-17
US20130274186A1
Chemistry; metallurgy

NEURTURIN MOLECULES

 #13 | 2013-01-31
US20130030180A1
Chemistry; metallurgy

Methods of facilitating neural cell survival using GDNF family ligand (GFL) mimetics or RET signaling pathway activators

 #14 | 2012-07-05
US20120171279A1
Chemistry; metallurgy

STRONGLY BOUND BASE-MODIFIED OLIGONUCLEOTIDES

 #15 | 2011-12-22
US20110312883A1
Chemistry; metallurgy

Neurturin molecules

 #16 | 2011-10-13
US20110251132A1
Chemistry; metallurgy

Treatment with a pharmaceutical composition comprising MANF2 necleic acid

 #17 | 2011-07-14
US20110171287A1
Chemistry; metallurgy

Use of Oligonucleotides with Modified Bases as Antiviral Agents

 #18 | 2011-06-23
US20110152346A1
Chemistry; metallurgy

Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids

 #19 | 2010-12-09
US20100311653A1
Chemistry; metallurgy

Splice variants of GDNF and uses thereof

 #20 | 2010-11-11
US20100285045A1
Chemistry; metallurgy

Novel Neurotrophic Factor Protein and Uses Thereof

 #21 | 2010-09-07
US10041224
-

Methods for preventing/treating damage to sensory hair cells and cochlear neurons

 #22 | 2009-11-12
US20090282495A1
Human necessities

Neurotrophic factor MANF and uses thereof

 #23 | 2009-02-10
US10203639
-

Compounds related to or derived from GFR α4 and their use

 #24 | 2008-10-30
US20080269154A1
Chemistry; metallurgy

MANF2 for treatment of Parkinson's disease

 #25 | 2008-03-20
US20080070264A1
Physics

Intracellular Signaling-Induced Ret-Independent Gdnf Receptor-Effected Morphological Changes

 #26 | 2008-03-06
US20080057516A1
Physics

Receptor for GDNF family ligands

 #27 | 2007-11-08
US20070259830A1
Chemistry; metallurgy

Antisense agents combining strongly bound base-modified oligonucleotide and artificial nuclease

 #28 | 2006-08-31
US20060195915A1
Chemistry; metallurgy

Novel neurotrophic factor protein and uses thereof

 #29 | 2006-04-20
US20060084619A1
Chemistry; metallurgy

Neurotrophic factor protein and uses thereof

 #30 | 2006-03-16
US20060057721A1
Chemistry; metallurgy

Method of screening cell death modulators

 #31 | 2005-06-14
US9410319
-

Ret-independent signaling pathway for GDNF
InventorID:

69130 ⎘